| N | % |
---|---|---|
Female/male | 27/24 | 53/47 |
Primary diagnosis unipolar depression | 46 | 90 |
Primary diagnosis bipolar depression | 5 | 10 |
Comorbidity | Â | Â |
 Anxiety disorders | 21 | 37 |
 Autism spectrum disorders | 5 | 10 |
 Attention deficit hyperactivity disorder | 11 | 22 |
 Personality disorders | 5 | 10 |
Supported housing | 7 | 14 |
Graduated from high school | 42 | 82 |
Working/studying at least half-time | 25 | 49 |
Medication | Â | Â |
 SSRI | 12 | 24 |
 SNRI | 16 | 31 |
 NaSSa | 13 | 25 |
 Bupropion | 5 | 10 |
 Tricyclic antidepressants | 7 | 14 |
 Mood stabilisers¶ | 13 | 25 |
 Stimulants¶ | 9 | 18 |
 Antipsychotics‡ | 11 | 22 |
 Olanzapine equivalent dose (mg/day, mean/SD) | 4.1 | 2.4 |
 | Mean | SD |
---|---|---|
Age (years) | 29.4 | 9.4 |
BMI (kg/m2) | 26.0 | 6.3 |
CAINS score (live) | 29.2 | 7.7 |
 Motivation and pleasure subscale | 21.4 | 5.9 |
 Expression subscale | 7.7 | 3.9 |
BPRS total score (video) | 46.6 | 6.3 |
 Negative symptoms subscale†| 7.9 | 3.3 |
 Positive symptoms subscale†| 3.4 | 0.9 |
 Affective symptoms subscale†| 12.4 | 2.9 |
 Anxiety and Tension items | 6.6 | 2.2 |
Maudsley Staging Method score | 11.8 | 12.6 |
CGI score | 4.9 | 0.8 |
MADRS-S total | 29.9 | 7.7 |
MADRS-S anhedonia* | 7.4 | 2.4 |
MADRS-S anxiety* | 3.6 | 1.3 |
EQ-VAS score | 34.4 | 15.7 |
Sheehan Disability Scale score | 17.5 | 7.5 |
AUDIT score | 4.7 | 4.1 |
Animal Naming Test** | 23.9 | 6.3 |
Digit Symbol Substitution Test*** | 50.5 | 18.2 |